Reducing Low‐Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?

Reducing Low‐Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?

Bibliographic Details
Main Author:	Lewis H. Kuller
Format:	Article
Language:	English
Published:	Wiley 2018-05-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials lipids myocardial infarction secondary prevention statin therapy
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.118.009430

Similar Items

Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
by: Ju Hyeon Kim, et al.
Published: (2022-05-01)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
by: William T. Wang, et al.
Published: (2018-02-01)

Early Effects of Treatment Low-dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
by: Olga Gruzdeva, et al.
Published: (2016-09-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong
by: Joseph E Blais, et al.
Published: (2022-09-01)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
by: Maciej Banach
Published: (2016-04-01)

Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction
by: LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong
Published: (2023-04-01)

Association between statin use and the prognosis of patients with acute myocardial infarction complicated with diabetes
by: Xuehao Lu, et al.
Published: (2022-08-01)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
by: Gruzdeva O, et al.
Published: (2017-12-01)

Incidence, Predictors and Outcomes of Subacute Stent Thrombosis following Primary Stenting for ST-elevation Myocardial Infarction
by: Su-Kiat Chua, et al.
Published: (2010-06-01)

Efficacy of Statin Treatment According to Baseline Renal Function in Korean Patients with Acute Myocardial Infarction Not Requiring Dialysis Undergoing Newer-Generation Drug-Eluting Stent Implantation
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

Stroke Risk Period After Acute Myocardial Infarction Revised
by: Jukka Putaala, et al.
Published: (2018-11-01)

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
by: Peter P. Toth, MD, PhD
Published: (2021-06-01)

Current possibilities in the outpatient treatment of postmyocardial infarction
by: Iu I Nesterov
Published: (2013-09-01)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
by: Min Chen, et al.
Published: (2023-05-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

Non-High-Density lipoprotein cholesterol or Apolipoprotein B in the prediction of myocardial infarction
by: Amit Kumar Pradhan, et al.
Published: (2017-04-01)

Blood Microbiota Modification After Myocardial Infarction Depends Upon Low‐Density Lipoprotein Cholesterol Levels
by: Jacques Amar, et al.
Published: (2019-10-01)

Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
by: Amgad Mentias, et al.
Published: (2020-06-01)

Statin Use in Cancer Patients with Acute Myocardial Infarction and Its Impact on Long-Term Mortality
by: Konrad Stepien, et al.
Published: (2022-07-01)

Predictive and Prognostic Value of High-density Lipoprotein Cholesterol in Young Male Patients with Acute Myocardial Infarction
by: Zhao Li, et al.
Published: (2017-01-01)

Impact of Mean and Variability of High‐Density Lipoprotein‐Cholesterol on the Risk of Myocardial Infarction, Stroke, and Mortality in the General Population
by: Byung‐Hun Han, et al.
Published: (2020-04-01)

The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
by: Stella Trompet, et al.
Published: (2022-01-01)

Selecting of statins optimum dosage regimen in patients with acute Q-wave myocardial infarction after thrombolytic therapy
by: V. D. Syvolap, et al.
Published: (2014-04-01)

Statin Eligibility and Outpatient Care Prior to ST‐Segment Elevation Myocardial Infarction
by: Michael D. Miedema, et al.
Published: (2017-04-01)

Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge
by: Víctor Marcos-Garcés, et al.
Published: (2023-12-01)

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction
by: Yan-Rong Li, et al.
Published: (2017-09-01)

Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

Questions of secondary prevention and rehabilitation of patients with myocardial infarction at different stages
by: A. D Kuimov, et al.
Published: (2015-06-01)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
by: J. Dawn Abbott, et al.
Published: (2023-08-01)

Early Readmissions After ST‐Segment–Elevation Myocardial Infarction: Glass Ceiling or Room for Improvement?
by: Beau M. Hawkins, et al.
Published: (2018-09-01)

The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction
by: Lotta Ulander, et al.
Published: (2023-09-01)

Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?
by: Aleksić Emina, et al.
Published: (2011-01-01)

Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries
by: Eun Ho Choo, et al.
Published: (2019-07-01)

Thrombolytic therapy in acute myocardial infarction at prehospital stage
by: A P Golikov, et al.
Published: (2004-01-01)

Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study
by: Celal Kilit, et al.
Published: (2017-04-01)

Secondary Prevention of Myocardial Infarction in People Living With HIV Infection
by: Sebhat Erqou, et al.
Published: (2020-09-01)

Unresolved issues of increasing physical activity after myocardial infarction
by: D. Yu. Sedykh, et al.
Published: (2022-06-01)

Relationship between low-density lipoprotein levels on admission and 1-year outcome in patients with acute ST-segment-elevation myocardial infarction
by: Yu-Jiao Sun, et al.
Published: (2013-04-01)

Impact of Low Baseline Low‐Density Lipoprotein Cholesterol on Long‐Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
by: Kyung Hoon Cho, et al.
Published: (2022-09-01)